Abstract #336 Metformin Use Reduces Serum Vitamin B12 Levels in Dose-Dependent and Timedependent Manner in Asian-Indians with Type 2 Diabetes

2019 ◽  
Vol 25 ◽  
pp. 147
Author(s):  
Sandeep Tak ◽  
Rajkumar Rathore ◽  
Ravi Mangalia
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin B12 ◽  
Asian Indians ◽  
Serum Vitamin ◽  
Dose Dependent

scholarly journals EVALUATION OF SERUM VITAMIN B12 LEVELS IN TYPE 2 DIABETES PATIENTS ON METFORMIN THERAPY ATTENDING A TERTIARY CARE HOSPITAL

2017 ◽  
Vol 4 (90) ◽  
pp. 5399-5404
Author(s):  
Anand Kalakappa Koppad ◽  
Gavisiddanagowda Patil ◽  
Basavaraj Devendrappa Baligar ◽  
Varun Bhaktarahalli Renukappa
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin B12 ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Serum Vitamin ◽  
Care Hospital ◽  
Metformin Therapy ◽  
Diabetes Patients

scholarly journals Vitamin B12 is Found Sufficient in Newly Diagnosed Type 2 Diabetes in a Hospital Based Study

2016 ◽  
Vol 1 (1) ◽  
Keyword(s):  
Type 2 Diabetes ◽  
Peripheral Neuropathy ◽  
Vitamin B12 ◽  
Serum Vitamin ◽  
Vitamin B12 Deficiency ◽  
Cross Sectional Study ◽  
Newly Diagnosed ◽  
Diabetes Group ◽  
Cross Sectional

Background: Vitamin B12 deficiency may be related to peripheral neuropathy in people with type 2 diabetes mellitus (T2DM). Level of B12 in T2DM observed by many investigators showed variable results. Studies on vitamin B12 in T2DM are very limited in Bangladesh. Objectives: To observe serum vitamin B12 level in newly diagnosed T2DM patients. Methods: Observational cross-sectional study encompassing 50 newly diagnosed T2DM and 50 controls as per American Diabetes Association (ADA) criteria. Vitamin B12 and Hemoglobin A1c (HbA1c) were measured for all. Results: Both mean (492.46±28.82 vs. 346.48±19.65 pg/mL, mean±SEM; p=<0.001) and median (435.50 vs. 334.50 pg/mL) values of serum vitamin B12 were found to be higher in T2DM than those of controls. None of the diabetic subjects were found to be B12 deficient whereas 6 were borderline deficient; these frequencies were 7 and 11 respectively among the controls. Vitamin B12 level was statistically similar in patients with or without clinically evident peripheral neuropathy (mean±SEM; 523.48±39.39 vs. 441.84±38.76 pg/mL, p=0.172). B12 level showed positive correlation with fasting plasma glucose (FPG, r=0.285, p=0.061) and HbA1c (r=0.287, p= 0.043) in diabetes group but there was no correlation with body mass index (BMI). Conclusion: Vitamin B12 is found sufficient in newly diagnosed Bangladeshi T2DM patients.

Association of Plasma Homocysteine and Macular Edema in Type 2 Diabetes Mellitus

2008 ◽  
Vol 18 (2) ◽  
pp. 226-232 ◽  
Author(s):  
E. Aydin ◽  
H.D. Demir ◽  
H. Ozyurt ◽  
I. Etikan
Keyword(s):  
Type 2 Diabetes ◽  
Diabetic Retinopathy ◽  
Folic Acid ◽  
Vitamin B12 ◽  
Macular Edema ◽  
Vitamin B6 ◽  
Serum Vitamin ◽  
Plasma Homocysteine ◽  
Significant Difference

Purpose The aim of this study was to assess the association of macular edema (ME) with plasma homocysteine, vitamin B6, vitamin B12, and folic acid levels in patients with Type 2 diabetes. Methods Sixty-five diabetic subjects with no retinopathy and nonproliferative diabetic retinopathy (NPDR) (no DR, without ME, with ME: 16, 25, 24, respectively), 28 with proliferative diabetic retinopathy (PDR) (with and without ME: 14, 14, respectively), and 19 healthy subjects as control were recruited in this cross-sectional study Plasma homocysteine, vitamin B12, vitamin B6, and folate levels were determined after 8-hour of fasting for all subjects. The levels of serum homocysteine and vitamin B6 were measured using high performance liquid chromatography (HPLC) with fluorescence detection, and the levels of serum vitamin B12 and folic acid were measured by electrochemiluminescence immunoassay. Results When diabetic groups with ME were compared with diabetic groups without ME for homocysteine, vitamin B12, vitamin B6, and folic acid, the only significant difference was detected in homocysteine levels (p=0.001). There was no significant difference between NPDR with ME group compared with NPDR without ME group and no DR group for plasma homocysteine, vitamin B12, vitamin B6, and folic acid (p=0.200, p=0.660; p=0.999, p=0.678; p=1.0, p=0.248; p=1.0, p=0.982, respectively). On the other hand, when PDR with ME group was compared with PDR without ME group, there was only significant difference in homocysteine levels (p=0.023). Conclusions Mild to moderate elevation of homocysteine may explain the role of vascular dysregulation and endothelial dysfunction in patients with DR. The present study suggests hyperhomocysteinemia may be one of the crucial risk factors for development of ME.

Association of serum vitamin D levels and diabetic retinopathy in Asian Indians with type 2 diabetes

2018 ◽  
Vol 139 ◽  
pp. 308-313 ◽  
Author(s):  
Beteal Ashinne ◽  
Ramachandran Rajalakshmi ◽  
Ranjit M. Anjana ◽  
K.M. Venkat Narayan ◽  
Ramamoorthy Jayashri ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin D ◽  
Diabetic Retinopathy ◽  
Asian Indians ◽  
Serum Vitamin ◽  
Serum Vitamin D ◽  
Vitamin D Levels

Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes

Biochimie ◽  
2013 ◽  
Vol 95 (5) ◽  
pp. 1056-1061 ◽  
Author(s):  
Rima Obeid ◽  
John Jung ◽  
Julia Falk ◽  
Wolfgang Herrmann ◽  
Jürgen Geisel ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin B12 ◽  
Serum Vitamin

scholarly journals The prevalence and treatment of metformin associated Vitamin B12 deficiency in patients with type 2 Diabetes Mellitus in New Zealand

2021 ◽  
Author(s):  
◽  
Sylvan Haeusler
Keyword(s):  
Type 2 Diabetes ◽  
New Zealand ◽  
Vitamin B12 ◽  
Treatment Options ◽  
Serum Vitamin ◽  
Vitamin B12 Deficiency ◽  
Zealand Population ◽  
B12 Deficiency

<p>With an ever increasing incidence of type 2 diabetes in the New Zealand population, continual assessment must be made to ensure the ongoing evaluation of treatment options to ensure patient care is not compromised. Previous research has shown higher prevalence of Vitamin B12 deficiency in patients with type 2 Diabetes Mellitus who have had long term metformin treatment. An investigation into patients attending secondary care clinics at the Diabetes Clinic at Wellington Regional Hospital as well as primary health care patients has explored the prevalence of this interaction in the New Zealand population as well as assessed the factors that may contributed to such an effect. It was found that there is a high prevalence of decreased serum Vitamin B12 level in patients with type 2 Diabetes exposed to metformin treatment. Factors such as age and ethnicity were seen to be key predictors of this interaction and have shown a unique view of how the population of New Zealand may be affected. Treatment of decreased serum Vitamin B12 levels was seen to be effective through both sublingual and intramuscular methods with variations in both short and long term effects. The use of sublingual treatment administration of Vitamin B12 supplementation is unique in the scope of metformin induced Vitamin B12 deficiency and has shown potential to be a therapeutic route for patients affected by such an interactions. Current views on the interaction between metformin and serum Vitamin B12 levels are currently under debate in regards to physiological relevance and clinical outcomes. This paper provides a first look at the effect of this interaction in a New Zealand population and evaluates treatment options for such. Furthermore a proposal is made for an alternate mechanism of metformin action on Vitamin B12 levels which may aid understanding of observations made in both in this paper and previous studies.</p>

Sign in / Sign up

Export Citation Format

Share Document